Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by JPPOUGET
Group name EquipeJPP
Item Type Journal Article
Title EFOMP policy statement NO. 19: Dosimetry in nuclear medicine therapy - Molecular radiotherapy
Creator Sjögreen-Gleisner et al.
Author Katarina Sjögreen-Gleisner
Author Glenn Flux
Author Klaus Bacher
Author Carlo Chiesa
Author Robin de Nijs
Author George C. Kagadis
Author Thiago Lima
Author Maria Lyra Georgosopoulou
Author Stephan Nekolla
Author Steffie Peters
Author Joao Santos
Author Bernhard Sattler
Author Caroline Stokke
Author Johannes Tran-Gia
Author Paddy Gilligan
Author Manuel Bardičs
Abstract The European Council Directive 2013/59/Euratom (BSS Directive) includes optimisation of treatment with radiotherapeutic procedures based on patient dosimetry and verification of the absorbed doses delivered. The present policy statement summarises aspects of three directives relating to the therapeutic use of radiopharmaceuticals and medical devices, and outlines the steps needed for implementation of patient dosimetry for radioactive drugs. To support the transition from administrations of fixed activities to personalised treatments based on patient-specific dosimetry, EFOMP presents a number of recommendations including: increased networking between centres and disciplines to support data collection and development of codes-of-practice; resourcing to support an infrastructure that permits routine patient dosimetry; research funding to support investigation into individualised treatments; inter-disciplinary training and education programmes; and support for investigator led clinical trials. Close collaborations between the medical physicist and responsible practitioner are encouraged to develop a similar pathway as is routine for external beam radiotherapy and brachytherapy. EFOMP's policy is to promote the roles and responsibilities of medical physics throughout Europe in the development of molecular radiotherapy to ensure patient benefit. As the BSS directive is adopted throughout Europe, unprecedented opportunities arise to develop informed treatments that will mitigate the risks of under- or over-treatments.
Publication Physica medica: PM: an international journal devoted to the applications of physics to medicine and biology: official journal of the Italian Association of Biomedical Physics (AIFB)
Volume 116
Pages 103166
Date 2023-12
Journal Abbr Phys Med
Language eng
DOI 10.1016/j.ejmp.2023.103166
ISSN 1724-191X
Short Title EFOMP policy statement NO. 19
Library Catalog PubMed
Extra PMID: 37926641
Tags Europe, first-last-coresponding, Humans, Policy, Radiometry
Date Added 2024/12/07 - 07:31:43
Date Modified 2024/12/15 - 12:14:38
Notes and Attachments Full Text (Attachment)
PubMed entry (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés